MedPath

ProsCan: Prostate cancer supportive care and patient outcomes project

Completed
Conditions
Prostate cancer
Patterns of care
Psychosocial and physical functioning outcomes
Genetics
Treatment-decison making
Economic Evaluation
Cancer - Prostate
Registration Number
ACTRN12607000233426
Lead Sponsor
The Cancer Council Queensland
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Male
Target Recruitment
1000
Inclusion Criteria

First histological diagnosis of prostate cancer of any stage
Diagnosed in Queensland
Ability to give informed consent
English-speaking
Access to telephone.
Additional inclusion criteria for the intervention component of the ProsCan project: Diagnosis of localised prostate cancer

Exclusion Criteria

Cognitive impairment.
Additional exclusion criteria for the intervention component of the ProsCan project: Locally advanced or metastatic prostate cancer Psychiatric illness Receiving active treatment for another cancer

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Efficacy of a telephone-based Support Intervention through improved psychosocial and physical functioning using the following measures: Decisional Conflict Scale; Decisional Regret Scale; Happiness Scale; Constructed Meaning Scale; Brief Distress Thermometer; Revised Impact of Events Scale; Short Form -36 (SF36 - Registered Trademark); Life Orientation Scale; International Prostate Symptom Score; Expanded Prostate Cancer Index Composite; Enhancing Recovery in Coronary Heart Disease (ENRICHD) Social Support Instrument; Satisfaction with Life Scale.[Baseline, 2, 6, 12, 24, 36, 48 and 60 months post-treatment.]
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath